News
RAUMEDIC and Sartorius Stedim Biotech Sign Partnership Agreement
Sartorius Stedim Biotech (SSB), an international leading pharma and biotech supplier, and RAUMEDIC, a leading worldwide OEM manufacturer of medical- and pharmaceutical-grade polymer components and...
News
Takeda to Acquire Nycomed
Takeda Pharmaceutical Company Limited jointly announced that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company...
News
Clinical phase III studies of Lu AA21004 presented for the first time at the 2011 Annual Meeting
H. Lundbeck A/S announced the presentation of new data from the clinical phase III program of Lu AA21004, an investigational compound for the treatment of...
News
Mylan Launches Generic Version of Percodan Tablets
Mylan Inc. announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone and Aspirin Tablets USP, 4.8355 mg/325 mg, based on an agreement with licensing...
News
Sun Pharma announces USFDA approval for DOCEFREZTM for Injection
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its New Drug Application (NDA) for DOCEFREZTM (docetaxel) for Injection,...
News
Almac Introduces selectAZyme
Almac’s biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of...
News
Seattle Genetics Announces Approval For FDA Accepts Brentuximab Vedotin BLAs
Seattle Genetics, Inc. announced that the U.S. Food and Drug Administration has accepted for filing two Biologics License Applications (BLAs) for brentuximab vedotin, including one...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.